isirv

Novel Antiviral Therapies for Influenza and Other Respiratory Viruses: Bench to Bedside 2 - 4 June 2015

Organising and Scientific Committees

Organising Committee	Scientific Advisory Committee
Robert Krug - Chair University of Texas at Austin Austin USA	Ruben Donis - Chair Center for Disease Control and Prevention Atlanta USA
Alan Hay - Co-chair NIMR London UK	Michael Ison - Co-chair Northwestern University Feinberg School of Medicine Chicago USA
Regina Dutkowski d3 Medicine, New Jersey New Jersey USA	Stephen Cusack EMBL Grenoble France
Frederick Hayden University of Virginia School of Medicine Charlottesville USA	John DeVincenzo University of Tennessee School of Medicine Memphis USA
Mark Krystal Bristol-Myers Squibb Company New York USA	George Gao Chinese Academy of Sciences Beijing China
Jane Ryan Consultant at Sementis Australia	Amy Krafft NIAID Rockville, MD USA
Jane Tao Rice University Houston USA	Jenny McKimm Breschkin CSIRO Materials Science and Engineering Parkville Australia
Sylvie van der Werf Institut Pasteur Paris France	Melissa Willis Biomedical Advanced Research and Development Authority (BARDA) Washington USA
Richard Whitley The University of Alabama at Birmingham Birmingham USA	Makoto Yamashita University of Tokyo Tokyo, Japan
	Hui-Ling Yen Division of Public Health Laboratory Sciences The University of Hong Kong Hong Kong SAR, China

Organising Committee

Bob Krug - Chairman
University of Texas at Austin
Austin
USA

Top

Skip to content

ISIRV LTD - Registered Address: Office 7, 35-37 Ludgate Hill, London EC4M 7JN United Kingdom | Registered Company Number: 6021083 (England & Wales) | Registered Charity Number: 1118829

isirv

Font Size

SCREEN

Profile

Direction

Menu Style